Work

Effects of Aprepitant on Drug Metabolism in Lymphoma Patients Receiving Multi-Day Chemotherapy Regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, + Rituxan (R/CHOP): Randomized, Cross-Over Study

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.1613.1613

Authors: Saroj Vadhan-Raj, Ivan Spasojevic, Xiao Zhou, Jorge E Romaguera, Michelle A. Fanale, Luis E Fayad, Nathan H. Fowler, Auris Huen, F.B. Hagemeister, Maria Alma Rodriguez, Sattva S. Neelapu, Felipe Samaniego, Anas Younes, Larry W Kwak

Institutions: The University of Texas MD Anderson Cancer Center, Duke Medical Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590721910

FWCI: 0.31

Cites:

Cited by: 4

Related to: 10